FATE icon

Fate Therapeutics

157 hedge funds and large institutions have $166M invested in Fate Therapeutics in 2024 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 45 increasing their positions, 47 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

less ownership

Funds ownership:

15% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 40

59% less capital invested

Capital invested by funds: $401M → $166M (-$235M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
157
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$91K
Puts
$39K
Net Calls
Net Calls Change

Top Buyers

1 +$5.03M
2 +$1.91M
3 +$1.68M
4
VPC
Vestal Point Capital
New York
+$1.29M
5
Citigroup
Citigroup
New York
+$1.17M

Top Sellers

1 -$19.5M
2 -$4.99M
3 -$3.4M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$3.04M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$3.04M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$21.2M
2
$18.1M
3
$17M
4
$7.99M
5
$7.23M
6
$5.87M
7
$5.58M
8
$5.38M
9
$5.03M
10
$4.78M
11
$4.66M
12
$4.09M
13
$4.07M
14
$3.68M
15
$3.68M
16
$3.06M
17
$2.77M
18
$2.75M
19
$2.62M
20
$2.54M
21
$2.43M
22
$2.35M
23
$2.28M
24
$1.82M
25
$1.79M